{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:28Z","timestamp":1789995028813,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ygyno.2017.03.025","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T04:01:17Z","timestamp":1491451277000},"page":"549-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous\/serous-like uterine cancers in BRCA1 mutation carriers"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4259-5992","authenticated-orcid":false,"given":"Laura J.","family":"Havrilesky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley A.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah D.","family":"Kauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2017.03.025_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","volume":"98","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.025_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.02.017","article-title":"Hereditary breast and ovarian cancer syndrome","volume":"113","author":"Bulletins ACoP","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"9597","key":"10.1016\/j.ygyno.2017.03.025_bb0015","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(07)61635-3","article-title":"Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"issue":"9566","key":"10.1016\/j.ygyno.2017.03.025_bb0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(07)60462-0","article-title":"Pelvic organ prolapse","volume":"369","author":"Jelovsek","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.025_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.2000.6003","article-title":"Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?","volume":"79","author":"Goshen","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.025_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/gyno.2000.6082","article-title":"Risk of endometrial carcinoma associated with BRCA mutation","volume":"80","author":"Levine","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2017.03.025_bb0035","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/IGC.0b013e3181ef622d","article-title":"BRCA1\/2 germline mutations in Jewish patients with uterine serous carcinoma","volume":"20","author":"Bruchim","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2017.03.025_bb0040","first-page":"1531","article-title":"BRCA germline mutations in women with uterine serous carcinoma\u2014still a debate","volume":"20","author":"Lavie","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2017.03.025_bb0045","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.03.025_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.025_bb0055","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2015 Sub (1973\u20132013) <Katrina\/Rita Population Adjustment> \u2212 Linked To County Attributes - Total U.S., 1969\u20132014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, (released April 2016, based on the November 2015 submission)."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.025_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2013.06.025","article-title":"How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis","volume":"131","author":"Havrilesky","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2017.03.025_bb0065","first-page":"1","article-title":"United States life tables, 2011","volume":"64","author":"Arias","year":"2015","journal-title":"Natl. Vital Stat. Rep."},{"issue":"10","key":"10.1016\/j.ygyno.2017.03.025_bb0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.025_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.10.390","article-title":"Decreasing utilization of hysterectomy: a population-based study in Olmsted County, Minnesota, 1965\u20132002","volume":"196","author":"Babalola","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.03.025_bb0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/AOG.0000000000000483","article-title":"Comparative effectiveness of robotically assisted compared with laparoscopic adnexal surgery for benign gynecologic disease","volume":"124","author":"Wright","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2017.03.025_bb0085","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1200\/JCO.2011.36.7508","article-title":"Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer","volume":"30","author":"Wright","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2017.03.025_bb0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jama.2013.186","article-title":"Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease","volume":"309","author":"Wright","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2017.03.025_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003677.pub5","article-title":"Surgical approach to hysterectomy for benign gynaecological disease","volume":"8","author":"Aarts","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.025_bb0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/AOG.0b013e3181ee6e4d","article-title":"Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer","volume":"116","author":"Barnett","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.03.025_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4293\/108680812X13462882736736","article-title":"Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies","volume":"16","author":"Wright","year":"2012","journal-title":"JSLS"},{"issue":"9","key":"10.1016\/j.ygyno.2017.03.025_bb0110","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States","volume":"100","author":"Yabroff","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2017.03.025_bb0115","author":"Halfhill"},{"key":"10.1016\/j.ygyno.2017.03.025_bb0120","series-title":"Healthcare Cost and Utilization Project (HCUP)","author":"(NIS) HNIS","year":"2012"},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.025_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.025_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2015.11.002","article-title":"Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy","volume":"140","author":"Tucker","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.025_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/AOG.0b013e318292aea4","article-title":"Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life","volume":"122","author":"Kuppermann","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.03.025_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2014.08.032","article-title":"Quality of life and pelvic floor dysfunction symptoms after hysterectomy with or without pelvic organ prolapse","volume":"182","author":"Humalajarvi","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.03.025_bb0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncr.23554","article-title":"Cost-effectiveness analysis of prevention strategies for gynecologic cancers in lynch syndrome","volume":"113","author":"Kwon","year":"2008","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581730241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581730241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T07:27:24Z","timestamp":1658906844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581730241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S009082581730241X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous\/serous-like uterine cancers in BRCA1 mutation carriers","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}